Invent radiopharmaceuticals for lives

Lays out oncology , neurology and cardiology
Who We Are?

A company ahead of the innovative radiopharmaceuticals in China.

Since 2014, Sinotau started the R&D of next-generation radiopharmaceuticals,which is an innovative pharmaceutical company specializing in the R&D, production, clinical application and marketing of radiopharmaceuticals

9

Year+

Years of radiopharmaceutical R&D
100

%

Focus on radiopharmaceuticals
3

+

Products
20

+

Pipeline
5

+

R&D and production sites
400

+

Skilled employees
80

+

Authorized Patent
Radiopharmaceutical Structure
 

Radioisotopes

beta- ,alpha-,and gamma- emitting isotopes

 

Coupling Agent

coupling of radioisotopes to targeting molecule

 

Targeting Molecule

Innovation

From precise diagnostics to targeted therapies, we pioneer next-generation solutions helping improve therapeutic outcomes and the lives of patients.

Sinotau has established differentiated and highly competitive pipeline out of high attention of the R&D innovation and for the sustainable development and theranostic radiopharmaceuticals with the characteristic and diverse innovation ability of our own team.

News

Sinotau is totally engrossed in reseach and development of radiopharmaceuticls. Learn about our latest progress.

Talent Development

We hope to invent radiopharmaceuticals for lives with you following the same heart and ideal. It’s a job, and moreover, it’s common endeavour.